A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
Clinical trial NCT06953323 · RECRUITING
Trial details
- NCT number
- NCT06953323
- Sponsor
- Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-10
- Primary completion
- 2029-06-30
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.